Canagliflozin (Renal) — Discount Pricing

Other medications in Diabetes & Metabolism

• Cinacalcet
• Dapagliflozin
• Dapagliflozin (CKD)
• Dulaglutide
• Empagliflozin
• Etelcalcetide
• Exenatide
• Finerenone

About Canagliflozin (Renal)

Canagliflozin renal is a vital medication for individuals managing type 2 diabetes and chronic kidney disease, working to protect kidney function and improve overall health. Understanding its benefits and how it works is crucial. At TheDrugClub, we believe access to essential medications shouldn't break the bank. Discover how our membership can provide significant savings on canagliflozin and many other prescriptions.

Canagliflozin, often referred to as "canagliflozin renal" in the context of its kidney-protective benefits, is a prescription medication primarily used to treat adults with type 2 diabetes. Beyond its role in blood sugar control, it's specifically indicated to reduce the risk of end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in patients with type 2 diabetes and diabetic kidney disease. It represents a significant advancement in managing the complex interplay between diabetes and kidney health, offering hope for slowing the progression of chronic kidney disease (CKD).

How Canagliflozin Works to Protect Your Kidneys

Canagliflozin belongs to a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors). These medications work in a unique way by targeting the kidneys. Normally, your kidneys reabsorb most of the glucose filtered from your blood. Canagliflozin, however, blocks the action of SGLT2 proteins in the kidneys, preventing the reabsorption of glucose and causing it to be excreted in the urine. This not only helps lower blood glucose levels but also contributes to several kidney-protective effects. By reducing pressure within the kidney's filtering units (glomeruli) and potentially decreasing inflammation, canagliflozin helps preserve kidney function over time, making it a cornerstone therapy for diabetic kidney disease.

Typical Costs and TheDrugClub Advantage

As a brand-name medication (marketed as Invokana), canagliflozin can be quite expensive. Without insurance, or with high-deductible

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Canagliflozin (Renal) is approved for (FDA label)

INVOKANA (canagliflozin) is indicated: as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus. to reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction and nonfatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD). to reduce the risk of end-stage kidney disease (ESKD), doubling of serum creatinine, cardiovascular (CV) death, and hospitalization for heart failure in adults with type 2 diabetes mellitus and diabetic nephropathy with albuminuria greater than 300 mg/day.

Source: Read the full FDA label on DailyMed. Label effective date: June 11, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.